EDS

The 2017 international classification of the Ehlers-Danlos syndromes.

The 2017 international classification outlines a newly revised framework for diagnosing Ehlers-Danlos Syndromes (EDS), expanding the list from the previous six subtypes to 13. This updated classification is based on both clinical and molecular criteria, reflecting the complexity and heterogeneity of EDS. While most EDS subtypes can now be diagnosed with molecular confirmation, hypermobile EDS remains an exception, as it primarily relies on clinical criteria. The classification aims to distinguish EDS from other heritable connective tissue disorders and to serve as a basis for future research, with the hope that a more comprehensive understanding will improve diagnosis and clinical outcomes.

Diagnosis / Diagnostic Criteria
Published March 18, 2017
The 2017 international classification of the Ehlers-Danlos syndromes.
Contributors
Source

American journal of medical genetics. Part C, Seminars in medical genetics

Medical Disclaimer

The purpose of this website is to inform and educate only. The information provided here is not intended to serve as professional medical advice, diagnosis, or treatment.

If you have health related issues, please contact a qualified health professional to get the personalized assessment, advice, and treatment that you need.

The creators of this living library, documentary and/or website will not be liable for any direct, indirect, or other damages arising from the use of these resources.